April 25, 2025

Multidimensional Sleep Health Affects Heart

Sleep is not a unitary physiologic experience, the AHA states in its new scientific statement, which redefines how physicians should assess sleep’s impact on cardiometabolic health.

Conexiant

April 24, 2025

Large Trial Finds No Stroke Benefit From CEP, Study

A large U.K. trial found that routine use of cerebral embolic protection did not decrease the incidence of stroke within 72 hours among patients undergoing TAVI.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 21, 2025

Risk-Free Midlife: 10+ Years Longer Living

Prioritizing the prevention and treatment of the modifiable risk factors could substantially extend healthy life expectancy worldwide.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 09, 2025

Daytime Eating Protects Night Shift Hearts

Restricting meals to daytime hours may reduce cardiovascular changes during simulated night shifts.

Conexiant

April 09, 2025

‘Weekend Warrior’ Exercise Pattern Cuts Risk of Death

Mortality benefits were similar among adults active only on weekends and those active throughout the week.

Conexiant

April 04, 2025

Warning Signs Before Sudden Cardiac Death

New research identified key clinical indicators that precede sudden arrhythmic death syndrome in patients under 36.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant